Hervana Bio is a biopharmaceutical company that develops womens health products. The company has developed a female contraceptive platform technology that is non-hormonal and offers protection against sexually transmitted infections. Hervanas LJ-102 is a highly effective, long-lasting contraceptive technology free from the drawbacks of current hormone-based contraceptives. The products safety profile and prolonged action enable greater compliance and accessibility, particularly in populations where the available methods of contraception are contraindicated, undesirable, or socially unacceptable. In 2012, Hervana Bio received a $1 million grant from the Bill and Melinda Gates Foundation.